AME AMETEK INC/
Industrial Instruments For Measurement, Display, and Control · NYSE · SEC CIK 1037868 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY14.3%
TTM net income YoY11.1%
TTM EPS YoY11.8%
Revenue 3-yr CAGR8.1%
Net income 3-yr CAGR8.5%
Margins
Gross margin36.4%
Operating margin26.0%
Net margin19.9%
FCF margin23.6%
EBITDA margin31.3%
Returns
ROE14.7%
ROA8.5%
ROIC (approx.)11.6%
Asset turnover0.42x
Leverage & solvency
Liabilities / assets47.8%
Debt / equity0.57x
Current ratio1.43x
Interest coverage18.76x
Cash quality & payout
Operating cash flow / net income1.28x
Accruals ratio-2.3%
Payout ratio18.7%
Capex / revenue1.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $7.40B | $6.94B |
| Cost of revenue | $4.73B | $4.46B |
| Gross profit | $2.67B | $2.48B |
| R&D expense | $236.10M | $236.60M |
| SG&A expense | $757.12M | $696.90M |
| Operating income | $1.91B | $1.78B |
| Interest expense | $81.25M | $112.96M |
| Pretax income | $1.80B | $1.66B |
| Income tax | $318.20M | $285.42M |
| Net income | $1.48B | $1.38B |
| EBITDA | $2.33B | $2.16B |
| EPS (basic) | 6.42 | 5.95 |
| EPS (diluted) | 6.40 | 5.93 |
| Weighted avg. shares (diluted) | 231.26M | 232.17M |
| Balance sheet | ||
| Cash & equivalents | $457.95M | $374.00M |
| Receivables | $1.12B | $948.83M |
| Inventory | $1.11B | $1.02B |
| Current assets | $3.02B | $2.60B |
| PP&E, net | $855.22M | $818.61M |
| Goodwill | $7.17B | $6.56B |
| Intangibles | $4.13B | $3.92B |
| Total assets | $16.07B | $14.63B |
| Current liabilities | $2.84B | $2.10B |
| Short-term debt | $1.21B | $654.35M |
| Long-term debt | $1.07B | $1.43B |
| Total debt | $2.28B | $2.08B |
| Total liabilities | $5.44B | $4.98B |
| Shareholders' equity | $10.63B | $9.66B |
| Net debt | $1.83B | $1.71B |
| Shares outstanding | 229.00M | 230.70M |
| Cash flow statement | ||
| Operating cash flow | $1.80B | $1.83B |
| Capital expenditure | $130.25M | $127.08M |
| Free cash flow | $1.67B | $1.70B |
| Investing cash flow | -$1.06B | -$244.81M |
| Financing cash flow | -$686.32M | -$1.60B |
| Depreciation & amortization | $422.80M | $382.93M |
| Stock-based compensation | $47.77M | $47.86M |
| Dividends paid | $285.35M | $258.78M |
| Share buybacks | $434.05M | $212.03M |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.